Showing 1 posts of 1 posts found.
UK drug development
 services firm Ergomed has appointed Peter George to its
board as a non-executive director.

 George has over 20 …
NEC joins €6.5m European project using AI for pandemic vaccine design
The evidence bar impacting UK medical cannabis access
Survey highlights mental health burden among rare disease patients and families
Addressing the rheumatic disease diagnostic gap in primary care
How chronic disease creates opportunity on diagnostic and therapeutic pipelines